Drug Information

Drug General Information
Drug ID
D01NBF
Former ID
DNC014840
Drug Name
3alpha-O-trans-p-coumaroyl-7-labden-15-oic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [525549]
Structure
Download
2D MOL

3D MOL
Formula
C28H38O5
Canonical SMILES
CC1=CCC2C(C1CCC(C)CC(=O)O)CCC(C2(C)C)OC(=O)C=CC3=CC=C(C<br />=C3)O
InChI
1S/C28H38O5/c1-18(17-26(30)31)5-12-22-19(2)6-14-24-23(22)13-15-25(28(24,3)4)33-27(32)16-9-20-7-10-21(29)11-8-20/h6-11,16,18,22-25,29H,5,12-15,17H2,1-4H3,(H,30,31)/b16-9+/t18-,22-,23+,24+,25-/m0/s1
InChIKey
ZSKLTPLHCIUPKA-LOWUFNJHSA-N
PubChem Compound ID
44566339
Target and Pathway
Target(s) DNA polymerase Target Info Inhibitor [525549]
References
Ref 525549J Nat Prod. 1999 Jul;62(7):1000-2.Harbinatic acid, a novel and potent DNA polymerase beta inhibitor from Hardwickia binata.
Ref 525549J Nat Prod. 1999 Jul;62(7):1000-2.Harbinatic acid, a novel and potent DNA polymerase beta inhibitor from Hardwickia binata.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.